Brown Gibbons Lang & Co.‘s client SourceBio International, a provider of laboratory services, has acquired LDPath Limited, a provider of pathology services. The acquisition creates a private provider of cellular and digital pathology services in the U.K.
SourceBio provides diagnostic testing and cellular pathology services to the U.K.’s National Health Service and other healthcare providers. LDP offers a proprietary intellectual property that was created with a focus on artificial intelligence to pioneer the creation of a Digital Pathology platform. The firm delivers its services to private healthcare providers and NHS trusts.
BGL’s Healthcare & Life Sciences investment banking team initiated the transaction and acted as the exclusive financial advisor to SourceBio.